Avinger (AVGR) Competitors $0.47 0.00 (0.00%) As of 07/1/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AVGR vs. BLAC, QNRX, CHEK, HSCS, ICU, AMIX, TIVC, PSTV, BBLG, and AEMDShould you be buying Avinger stock or one of its competitors? The main competitors of Avinger include Bellevue Life Sciences Acquisition (BLAC), Quoin Pharmaceuticals (QNRX), Check-Cap (CHEK), HeartSciences (HSCS), SeaStar Medical (ICU), Autonomix Medical (AMIX), Tivic Health Systems (TIVC), Plus Therapeutics (PSTV), Bone Biologics (BBLG), and Aethlon Medical (AEMD). These companies are all part of the "medical equipment" industry. Avinger vs. Its Competitors Bellevue Life Sciences Acquisition Quoin Pharmaceuticals Check-Cap HeartSciences SeaStar Medical Autonomix Medical Tivic Health Systems Plus Therapeutics Bone Biologics Aethlon Medical Avinger (NASDAQ:AVGR) and Bellevue Life Sciences Acquisition (NASDAQ:BLAC) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, risk, valuation, analyst recommendations, dividends, earnings and profitability. Which has higher valuation and earnings, AVGR or BLAC? Bellevue Life Sciences Acquisition has lower revenue, but higher earnings than Avinger. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAvinger$7.65M0.21-$18.32M-$11.06-0.04Bellevue Life Sciences AcquisitionN/AN/AN/AN/AN/A Is AVGR or BLAC more profitable? Company Net Margins Return on Equity Return on Assets AvingerN/A N/A N/A Bellevue Life Sciences Acquisition N/A N/A N/A Do insiders & institutionals believe in AVGR or BLAC? 18.3% of Avinger shares are held by institutional investors. Comparatively, 55.3% of Bellevue Life Sciences Acquisition shares are held by institutional investors. 42.8% of Avinger shares are held by company insiders. Comparatively, 33.7% of Bellevue Life Sciences Acquisition shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has more volatility & risk, AVGR or BLAC? Avinger has a beta of 1.29, meaning that its share price is 29% more volatile than the S&P 500. Comparatively, Bellevue Life Sciences Acquisition has a beta of -0.08, meaning that its share price is 108% less volatile than the S&P 500. Does the media favor AVGR or BLAC? In the previous week, Avinger's average media sentiment score of 0.00 equaled Bellevue Life Sciences Acquisition'saverage media sentiment score. Company Overall Sentiment Avinger Neutral Bellevue Life Sciences Acquisition Neutral SummaryAvinger beats Bellevue Life Sciences Acquisition on 3 of the 4 factors compared between the two stocks. Get Avinger News Delivered to You Automatically Sign up to receive the latest news and ratings for AVGR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AVGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AVGR vs. The Competition Export to ExcelMetricAvingerMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.57M$6.86B$5.53B$9.05BDividend YieldN/A1.21%5.24%4.03%P/E Ratio-0.0426.1527.5220.22Price / Sales0.2199.70421.02118.64Price / CashN/A21.0936.8958.07Price / Book-0.104.748.045.67Net Income-$18.32M$173.18M$3.18B$249.13M7 Day PerformanceN/A1.33%2.90%3.28%1 Month PerformanceN/A0.16%3.70%5.55%1 Year Performance-73.37%23.71%36.15%21.12% Avinger Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AVGRAvingerN/A$0.47flatN/AN/A$1.57M$7.65M-0.0470BLACBellevue Life Sciences AcquisitionN/A$1.54-4.9%N/A-87.5%$6.22MN/A0.00N/AHigh Trading VolumeQNRXQuoin Pharmaceuticals0.5382 of 5 stars$8.58-1.4%N/A-55.2%$5.12MN/A-0.184Gap UpCHEKCheck-Cap0.4747 of 5 stars$0.75+1.6%N/A-64.2%$4.32MN/A-0.2580News CoverageHSCSHeartSciences1.6752 of 5 stars$3.79+0.8%$13.00+243.0%-22.6%$4.06M$20K-0.5110News CoverageICUSeaStar Medical1.2026 of 5 stars$0.33-5.8%N/A-94.1%$3.95M$140K-0.102High Trading VolumeAMIXAutonomix Medical3.2876 of 5 stars$1.34+8.1%$16.50+1,131.3%-89.0%$3.45MN/A-0.181Negative NewsGap UpTIVCTivic Health Systems0.4799 of 5 stars$3.88+2.1%N/A-37.4%$3.34M$780K0.0010Gap UpPSTVPlus Therapeutics1.6806 of 5 stars$0.18-5.0%$11.67+6,230.3%-80.7%$3.30M$5.82M-0.0620High Trading VolumeBBLGBone Biologics1.105 of 5 stars$6.20+4.9%N/A-51.7%$3.22MN/A0.002AEMDAethlon Medical3.0101 of 5 stars$1.40-11.4%$56.00+3,900.0%-60.3%$3.18M$570K-0.1110Analyst Revision Related Companies and Tools Related Companies Bellevue Life Sciences Acquisition Alternatives Quoin Pharmaceuticals Alternatives Check-Cap Alternatives HeartSciences Alternatives SeaStar Medical Alternatives Autonomix Medical Alternatives Tivic Health Systems Alternatives Plus Therapeutics Alternatives Bone Biologics Alternatives Aethlon Medical Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AVGR) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe mainstream media is wrong about AI — againThe mainstream media got it wrong … yet again. AI has recently turned the tech world on its head. And th...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avinger, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avinger With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
